Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 25 , ISSUE 11 ( November, 2021 ) > List of Articles

EDITORIAL

Unraveling the Worth of a Clinical Pharmacist

Keywords : Chronic kidney disease, Clinical pharmacist, Drug–drug interaction

Citation Information : Unraveling the Worth of a Clinical Pharmacist. Indian J Crit Care Med 2021; 25 (11):1215-1216.

DOI: 10.5005/jp-journals-10071-24031

License: CC BY-NC 4.0

Published Online: 16-11-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

HTML PDF Share
  1. The definition of clinical pharmacy. Pharmacotherapy 2008;28(6):816–817. DOI: 10.1592/phco.28.6.816.
  2. Calvert RT. Clinical pharmacy—a hospital perspective. Br J Clin Pharmacol 1999;47(3):231. DOI: 10.1046/j.1365-2125.1999.00845.x.
  3. Hisham M, Sivakumar MN, Veerasekar G. Impact of clinical pharmacist in an Indian Intensive Care Unit. Indian J Crit Care Med 2016;20(2):78. DOI: 10.4103/0972-5229.175931.
  4. Fincke BG, Snyder K, Cantillon C, Gaehde S, Standring P, Fiore L, et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf 2005;14(2):121–128. DOI: 10.1002/pds.966.
  5. Fitzmaurice MG, Wong A, Akerberg H, Avramovska S, Smithburger PL, Buckley MS, et al. Evaluation of potential drug–drug interactions in adults in the intensive care unit: a systematic review and meta-analysis. Drug Saf 2019;42(9):1035–1044. DOI: 10.1007/s40264-019-00829-y.
  6. Papotti B, Marchi C, Adorni MP, Potì F. Drug-drug interactions in polypharmacy patients: the impact of renal impairment. Curr Res Pharmacol Drug Discov 2021;2:100020. DOI: 10.1016/j.crphar.2021.100020.
  7. Schmidt IM, Hübner S, Nadal J, Titze S, Schmid M, Bärthlein B, et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study. Clin Kidney J 2019;12(5):663–672. DOI: 10.1093/ckj/sfz046.
  8. Matzke GR, Aronoff GR, Atkinson Jr AJ, Bennett WM, Decker BS, Eckardt KU, et al. Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011;80(11):1122–1137. DOI: 10.1038/ki.2011.322.
  9. Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug-drug interactions among renal failure patients of nephrology ward in a South Indian tertiary care hospital. Indian J Pharm Sci 2012;74(1):63. DOI: 10.4103/0250-474X.102545.
  10. Aghili M, Kasturirangan MN. Management of Drug–Drug Interactions among Critically Ill Patients with Chronic Kidney Disease: Impact of Clinical Pharmacist's Interventions. Indian J Crit Care Med 2021;25(11):1226–1231.
  11. Arredondo E, Udeani G, Horseman M, Hintze TD, Surani S. Role of clinical pharmacists in intensive care units. Cureus 2021;13(9). DOI: 10.7759/cureus.17929.
  12. Hazen A, Sloeserwij V, Pouls B, Leendertse A, de Gier H, Bouvy M, et al. Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care. Int J Clin Pharm 2021;43(5):1155–1162. DOI: 10.1007/s11096-021-01304-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.